One-Page Summary
Aptiv screens as one of the cheapest names in auto supply — 5.9x EV/EBITDA and 7.7x forward adjusted EPS — and the headline "down 40% in a year" that makes it look like a value trap is roughly half an accounting artifact: the April 1, 2026 Versigent (NYSE: VGNT) spin-off distributed real value out of the APTV share price without any adjustment to the quoted history. Add back the 0.333 VGNT shares per APTV share and six-month total shareholder return is approximately flat, not −26.6%. The genuine damage is narrower and more recent: an August 4 guidance cut driven by Chinese domestic OEM weakness, followed by sequential sell-side downgrades and a September index deletion. We rate the shares BUY on valuation and insider conviction, while acknowledging that nothing in the tape says the selling is finished.
Top 5 Reasons
- The decline is mismeasured. $44.16 + (0.333 × $47.52 VGNT) ≈ $59.98 versus $60.16 on 3/31/2026 — the pre-spin reference point. Screens and unadjusted charts overstate the loss by roughly 20 percentage points.
- Valuation is genuinely cheap on clean post-spin numbers. FY2026 guidance of $12.6–12.8B revenue and $5.60–5.80 adjusted EPS puts the stock at 7.7x forward adjusted earnings and 5.9x guided EBITDA, against a peer EV/EBITDA median near 9.8x and peer forward P/E of roughly 11–16x.
- Insiders bought the dip with personal capital. Four separate insiders — CEO Kevin Clark (51,190 shares at ~$48.89) plus directors Paul Meister (105,631 at ~$47.33), Sean Mahoney (11,000 at ~$50.29) and Hakan Agnevall (4,100 at ~$48.58) — purchased in the two weeks after the August selloff.
- Balance sheet is materially better post-spin. The $1.9B Versigent dividend retired $1,847M of senior notes; debt/equity fell from 0.82x to ~0.6x, with $1.8B of buyback authorization still outstanding.
- Margin trajectory is improving even after the cut. Guided FY2026 adjusted EBITDA margin of 18.4% compares with a charge-depressed 5.80% FY2025 operating margin; Q2'26 came in at 18.7%.
The honest counterweight: the $300M guidance cut was real, half of it from Chinese domestic OEM share loss that is structural rather than cyclical, and price sits 26% below its 200-day average with a death cross active. This is a valuation call made against adverse momentum — size and stage accordingly.
1. Company Overview
Aptiv PLC (NYSE: APTV) is a global automotive technology supplier in signal/power distribution, advanced safety and user experience, and software-defined vehicle architecture. Sector: Consumer Discretionary; Industry: Auto Parts: O.E.M. Market capitalization is approximately $9.17B on roughly 207.6M implied shares, with no dividend reported.
The defining corporate event of the period is the completed separation of the Electrical Distribution Systems (EDS) segment as Versigent PLC (NYSE: VGNT) on April 1, 2026, distributed at one VGNT share per three APTV shares held on the March 17, 2026 record date. Aptiv received a $1.9B cash dividend from Versigent at completion and used it to redeem $1,847M of senior notes early. "New Aptiv" is a smaller, higher-margin, less-levered electronics and software business.
Business Quality — Moat width: Narrow
- Deep OEM design-win relationships in safety-critical ADAS/active-safety and software-defined-vehicle architecture create multi-year switching costs once a platform is qualified.
- Engineering/manufacturing scale in signal, power and compute systems amortized across a broad global OEM customer base.
- Eroding pricing power: capital-intensive, highly cyclical, and structurally exposed to Chinese domestic-OEM share gains at the expense of the multinational/JV automakers that are Aptiv's core customers — the moat is weakening, not widening.
Data integrity notes (read before using any figure)
Two vendor errors were caught and corrected during this research, and both materially change the picture:
- Nasdaq's Q2 FY2026 revenue of $1.220B is wrong. Aptiv's 8/4/2026 8-K (SEC EDGAR, exhibit 99.1) reports Q2 2026 GAAP revenue of $3.3B, +2% YoY, continuing operations. The vendor figure appears to be a data error, not a reporting line.
- The quoted price-change history is not spin-adjusted, so every period spanning April 1, 2026 overstates the decline. See Section 3.
- Nasdaq's $67.50 one-year target is stale. Post-cut sell-side targets cluster at $55–$65 (JPMorgan $56, Argus $64, Barclays $65, Morgan Stanley $55, Goldman $71). Some aggregators still display a $74–$77 average that predates the August cut. Our $58 fair value is set independently of all of these.
- Trailing EPS, trailing P/E, and exact 6/30/2026 book value remain formally unresolved because the trailing four quarters straddle the spin. We use forward guided figures instead and label them as such rather than publishing a trailing multiple we cannot stand behind.
2. Price Chart
3. Technical Setup
Trend
Severe multi-year downtrend with acceleration (−40.57% YoY, −48.55% in 3Y), but price just tested a fresh 200-day low yesterday and recovered +2.65% today — potential base formation near support.
Wyckoff Phase
Markdown (late stage) → Early Accumulation. The stock sits precisely at the 200-day low ($43.02, set yesterday), only 6.4% above the 5-year floor ($41.52). Death cross is active; price is 26.2% below the 200-day MA. This extreme compression — coupled with the EDS spin-off caveat — suggests capitulation may be near completion rather than ongoing.
Key Levels
| Level | Price | Significance |
|---|---|---|
| R2 (5yr high) | $154.32 | Invalidates recovery thesis; ~3.5x away |
| R1 (200d high) | $76.82 | Psychological target; +73.9% |
| Current | $44.16 | Just above fresh support |
| S1 (200d low) | $43.02 | Set yesterday; price at edge |
| S2 (5yr low) | $41.52 | Hard floor; −6.0% away |
Moving averages and volume
- 50-day SMA $48.21 (price 8.4% below); 200-day SMA $59.85 (price 26.2% below); 50-MA below 200-MA, death cross active.
- Today's volume 1,512,212 against 2,126,102 average — 71% of normal, which argues the bounce lacks conviction.
Spin-adjusted return — the critical correction
The unadjusted table below is what screens show. It is misleading across the April 1, 2026 boundary because APTV's price was not adjusted for the in-kind VGNT distribution.
| Period | Headline (unadjusted) | From | Spin-adjusted reality |
|---|---|---|---|
| 1 Week | −2.24% | $45.17 (09/23/2026) | −2.24% (post-spin, real) |
| 1 Month | −1.34% | $44.76 (08/31/2026) | −1.34% (post-spin, real) |
| 3 Months | −26.74% | $60.28 (07/01/2026) | −26.74% — real, driven by the Aug 4 cut and downgrades |
| 6 Months | −26.60% | $60.16 (03/31/2026) | ≈ 0% (roughly flat) adding back 0.333 VGNT at $47.52 |
| 1 Year | −40.57% | $74.31 (09/29/2025) | ≈ −19.3% on the same adjustment |
| 3 Years | −48.55% | $85.84 (09/25/2023) | Overstated by the same artifact |
Entry Strategy
- Bullish: Buy zone $41.50–$43.50 (at/below support confirmation with volume), stop loss $40.00 (5yr low break).
- Bearish: Short zone $44.50–$46.00 (resistance from recent price), stop loss $48.50 (above 50-day SMA). Target $38.00–$40.00 (5yr low break + 5% panic margin).
Ant's Verdict
WAIT FOR PULLBACK — multi-year lows attract value accumulation, but today's sub-average volume (71% of daily avg) and yesterday's fresh low suggest the capitulation signal is incomplete; buy confirmation on a second touch of $41.50–$43.00 with expanding volume, or await a relief rally bounce toward $48–$50 to establish risk/reward clarity.
4. Financial Health
| Metric | Value | Source | Assessment |
|---|---|---|---|
| Revenue TTM | Not meaningful / unresolved — spans the 4/1/2026 structural break | FY2025 consolidated (pre-spin): $20.398B (10-K); FY2026E continuing-ops guidance: $12.6–12.8B (8-K, 8/4/2026) | Use FY2026 guidance as the clean forward base; any TTM sum mixes divested EDS with continuing ops |
| Revenue (prior Q, Q2'26) | $3.3B, +2% YoY, continuing ops | SEC 8-K 8/4/2026 (aptvq22026ex991.htm) — verified, corrects vendor's $1.220B error | In line with estimates |
| Free Cash Flow | Q2'26: $12M (vs $219M Q2'25); FY2026 guide: $625–725M | SEC 8-K | Weak quarter on separation costs/working capital; guidance implies ~5.3% FCF margin |
| Cash on Hand | $761M (6/30/2026), down from $1,575M at 12/31/2025 | SEC 8-K | Spin dividend was redeployed to debt paydown |
| EBITDA | Q2'26 adj. EBITDA $613M (18.7% margin); FY2026 guide: $2,310–2,370M (18.4% margin) | SEC 8-K | Clean improvement vs. FY2025's charge-depressed 5.80% operating margin |
| Profit Margin | FY2026 guided net margin (continuing ops) ~6.9% ($860–900M / $12.6–12.8B); Q2'26 actual 9.0% ($298M/$3.3B) | SEC 8-K | Far better than FY2025's distorted 0.81% (included $833M non-recurring charges + EDS drag) |
| Book Value | ~$8.75B equity / ~$42/sh (6/30/26) — not independently confirmed to the dollar | Primary source confirms $9,207M equity / 213M shares at 1/1/2026 (10-Q) | Plausible given $1.9B spin dividend used for debt paydown, but exact 6/30/26 balance unverified |
| EPS TTM | UNRESOLVED — trailing 4 quarters straddle the spin; not comparable | Pro forma FY2025 continuing-ops EPS: $(0.20) incl. $648M goodwill impairment (8-K/A unaudited pro forma) | Use FY2026 guided diluted EPS (continuing ops) $4.06–4.26, adj. EPS $5.60–5.80 instead |
| Debt/Equity | ~0.58–0.61x ($5,354M debt / ~$8.75–9.2B equity) | Debt verified (SEC 8-K); equity partially unverified | Improved from FY2025's 0.82x via spin-funded debt paydown |
| P/E (Trailing) | UNRESOLVED — see EPS TTM | — | Distorted by spin and one-time charges |
| Forward P/E | ~7.7x (adj. EPS $5.70 midpoint) / ~10.6x (GAAP diluted continuing-ops EPS $4.16 midpoint) | SEC 8-K guidance ÷ $44.16 spot | Screens cheap vs. peer forward multiples (~11–16x) |
Supporting liquidity and returns data (vendor, 6/30/2026): current ratio 201.8%, quick ratio 133.3%. FY2025 after-tax ROE of 1.79% is not representative — it reflects $833M of non-recurring charges against a pre-spin equity base.
Valuation vs Peers
| Metric | APTV | BorgWarner (BWA) | Magna (MGA) | Sector Avg |
|---|---|---|---|---|
| P/E (trailing) | Unresolved (spin break) | 46.7x (distorted by one-offs) | 9.4x | ~28.8x (skewed by Mobileye's 88x; median closer to ~10x) |
| Forward P/E | ~7.7x (adj.) / ~10.6x (GAAP) | ~11.2–11.8x (2026E) | Not independently verified | ~15.7x (sector median) |
| P/B | ~1.05x (equity unverified) | 1.61x | 1.41x | ~1.4x (partial sample) |
| EV/EBITDA | ~5.9x (EV $13.76B ÷ FY26 guided EBITDA $2.34B midpoint — calculated) | 10.18x | n/a (not sourced) | 9.84x (sector median) |
| Revenue Growth | +2% (FY2026 guided, continuing-ops base) | −3.5% to −1.5% organic (2026 guide) | +0.74% (TTM) | roughly flat-to-negative across ICE/EV-transition-exposed suppliers |
| Profit Margin | ~6.9% (FY2026 guided net margin) / 9.0% (Q2'26 actual) | 0.94% (TTM) | 1.78% | ~3% (sector depressed broadly) |
5. Ownership & Capital Structure
Active/Hedge Fund Holders (ETFs/index funds excluded; 13F-aggregator data, not independently cross-checked against raw SEC 13F filings — treat as approximate):
| Holder | Shares | Value | Type |
|---|---|---|---|
| Viking Global Investors | 4,552,887 | $279.5M | Hedge fund (long/short equity) |
| Impax Asset Management | 4,087,314 | $250.9M | Active fundamental manager |
| Slate Path Capital | 2,650,115 | $162.7M | Hedge fund |
| Mangrove Partners | 613,392 | n/a | Hedge fund |
| AQR Capital Management | 552,805 | $33.5M | Quant/systematic hedge fund |
Excluded as passive: BlackRock, Vanguard, State Street, Norges Bank, Dimensional, First Trust.
Recent Funding / Capital Markets Activity
- Aptiv received a $1.9B cash dividend from Versigent at spin completion (4/1/2026), used to redeem $1,847M of senior notes early.
- Versigent capitalized itself independently via a $1.35B senior secured credit facility (Nov 2025, JPMorgan-led) and $1.6B senior notes priced 3/18/2026 ($800M 6.125% due 2031 + $800M 6.375% due 2034) through subsidiaries Cyprium U.S./Cyprium Luxembourg.
- Aptiv share repurchases: $325M YTD through Q2 2026 ($250M in Q2 alone, 4.1M shares retired); $1.8B remains under existing authorization.
- Fitch placed Aptiv's ratings on Rating Watch Negative upon the spin announcement, citing reduced post-spin scale/EBITDA leverage risk. Final rating resolution post-completion could not be confirmed — unresolved.
6. Competition & Sector
| Competitor | Market Cap | Trailing P/E | Note |
|---|---|---|---|
| BorgWarner (BWA) | ~$12.5B | 46.7x (distorted) | 2026 guide implies organic sales down 1.5–3.5% |
| Magna (MGA) | ~$16.8B | 9.4x | TTM revenue $42.3B, margin compression |
| Lear (LEA) | ~$6.2B | 8.8x | EV/EBITDA 6.63x, near 10-yr median |
| Visteon (VC) | ~$2.6B | 11.3x | Cockpit electronics pure-play |
| Mobileye (MBLY) | ~$6.65B | 88x (33x non-GAAP fwd) | Growth premium, ADAS/AV software |
| Sensata (ST) | ~$6.8B | 8.4x | Q2'26 revenue +5% YoY, adj. EPS +12.6% |
Tailwinds
- FY2026 adjusted EBITDA guidance still implies margin expansion (18.4% midpoint) despite the cut.
- $1.8B buyback authorization remaining provides EPS support at a depressed valuation.
- Post-spin balance sheet is simpler and less levered (D/E ~0.6x vs 0.82x pre-spin).
- Non-automotive optionality: first commercial drone award won (>$500M lifetime revenue over a 5-year program), with management targeting ~$300M annual robotics/drone revenue within several years and ~$4B non-auto revenue (27% of sales) by 2028 per the Nov 2025 Investor Day.
Headwinds
- China domestic retail sales reportedly down ~20%; local OEMs cutting 2H26 production on Aptiv-supplied platforms — drove ~$150M of the $300M FY2026 guidance cut.
- Luxury European OEMs cutting China-export production — compounding headwind.
- ~$100M guidance impact from delayed program launches/ramps.
- Multiple analyst price-target cuts in Aug–Sep 2026 (Morgan Stanley to $55 from $71 with downgrade to Equal Weight; Barclays to $65 from $73; Goldman Sachs to $71; Argus to $64; JPMorgan to Neutral/$56).
7. 12-Month Catalyst Timeline
| Date/Quarter | Catalyst | Type | Impact |
|---|---|---|---|
| Oct 29, 2026 | Q3 2026 earnings (first full post-guidance-cut quarter) | Earnings | High |
| Ongoing Q4'26 | China domestic OEM production/SAAR trends | Macro | High |
| Q4 2026–Q1 2027 | Continued execution of $1.8B buyback authorization | Capital allocation | Medium |
| Early Jan 2027 (exact date TBD) | CES 2027 — ADAS/software-defined vehicle platform updates | Industry event | Medium |
| ~Feb 2027 | Q4/FY2026 earnings + initial FY2027 guidance | Earnings | High |
| Unresolved/ongoing | Fitch Rating Watch Negative resolution | Credit | Medium |
| April 2027 | First clean YoY comp quarter (laps the EDS spin structural break) | Reporting | Medium |
8. Recent News
| Date | Outlet | Headline | Material? |
|---|---|---|---|
| Sep 19, 2026 | FTSE Russell / covered by Simply Wall St | Aptiv removed from the FTSE All-World Index (USD terms), a technical/passive-flow event that can trigger forced index-fund selling | Yes — flow-driven, not fundamental |
| Sep 15, 2026 | (reported via Bitget News, citing JPMorgan research) | JPMorgan downgrades Aptiv to Neutral from Overweight, cuts price target to $56 from $65 | Yes |
| Aug 13, 2026 | Investing.com (Argus research note) | Argus lowers Aptiv price target to $64 from $69, maintains Buy rating, cites regional (China) weakness | Yes |
| Aug 10, 2026 | ad-hoc-news.de / wire coverage | Barclays cuts Aptiv price target to $65 from $73, keeps Overweight | Yes |
| Aug 5–13, 2026 | SEC Form 4 filings (via TipRanks/OpenInsider) | Cluster of insider buying right after the post-earnings selloff: CEO Kevin Clark bought 51,190 shares ( |
Yes — notable insider conviction at the lows |
| Aug 4, 2026 | Aptiv press release / Investing.com, Fool.com transcripts | Q2 2026 results: revenue $3.3B (+2%), adjusted EPS $1.63 (beat), but FY2026 guidance cut by $300M at the midpoint — revenue now $12.6–$12.8B (was $12.8–$13.2B), adjusted EPS $5.60–$5.80 (was $5.70–$6.10); stock fell ~14–18% on the print despite the beat | Yes — highly material |
| Jul 2026 | Aptiv Q2 earnings call commentary (Kevin Clark) | First commercial drone award won, lifetime revenue expected >$500M over a 5-year program; robotics partnerships advancing to commercial stage; management targets ~$300M in annual robotics/drone revenue within several years | Yes — strategic diversification narrative |
| Apr 1, 2026 | Aptiv/Versigent press releases, Gasgoo/trade press | Versigent (EDS business) spin-off completed; began regular-way trading on NYSE as VGNT; Aptiv shareholders received 1 Versigent share per 3 Aptiv shares held (record date Mar 17, 2026) | Yes — structural break, explains the Q2'26 revenue/debt discontinuity |
| Feb 2, 2026 | Fool.com / Investing.com transcripts | Q4 2025 earnings beat (EPS $1.86 vs. $1.84 est.; revenue $5.2B vs. $5.09B est.) but stock dipped on the print; FY2025 revenue $20.4B, adjusted EPS $7.82 | Yes (pre-spin baseline) |
| Nov 18, 2025 | Aptiv Investor Day (company materials, TipRanks, TradingView) | Aptiv lays out post-spin targets: "New Aptiv" to grow revenue 4–7%/yr through 2028, ~200bps EBITDA margin expansion, ~$4B cumulative FCF 2026–28; non-auto revenue targeted near $4B (27% of sales) by 2028 | Yes — framework guidance now being tested by the Aug cut |
9. M&A & Rumor Watch
- No credible takeover or activist-campaign rumor specific to Aptiv itself was found. One search surfaced only a passing note that Atlantic Investment Management added spin-off entity Versigent to its Q2 2026 13F — not an activist stake in APTV.
- The dominant corporate action of the period is not M&A but the completed EDS separation into Versigent (VGNT), finalized April 1, 2026 — a planned tax-free spin, not a rumor.
- The insider buying cluster is the notable signal. Four separate insiders (CEO + three directors) bought stock in the first two weeks of August 2026 at roughly $47–$50 — i.e., above today's $44.16. Insiders bought and the stock has fallen further since, so this has not yet worked. It is a conviction datapoint, not a timing signal.
- Consensus-target hygiene: the $67.50 figure carried by some data vendors looks stale. Fresh post-cut analyst targets cluster at $55–$65; some aggregators still display $74–$77 averages. Any valuation argument built on "upside to consensus" needs a freshly timestamped number.
10. Social Sentiment
- Overall mood: Mixed-to-bearish. Sell-side commentary has turned more negative since August (multiple price-target cuts), while a smaller high-conviction contingent (Argus, company insiders) is buying the dip.
- Retail vs Institutional: Retail chatter is notably thin — one sentiment tracker (AltIndex) showed Reddit mentions near zero per day with a roughly neutral score (~69/100), indicating APTV is not a retail/meme name right now. Institutional debate centers on China auto demand (a ~20% decline in China domestic retail sales cited as the proximate cause of the guidance cut) versus the longer-dated bull case (software-defined vehicle content, robotics/drone diversification).
- Trending narratives: (1) China domestic auto weakness and delayed OEM program launches as the key earnings risk; (2) the "post-spin re-rating" question — is New Aptiv a cleaner, higher-margin electronics/software pure-play, or is the market still mispricing it after the EDS separation and FTSE index exit; (3) early-stage optionality in commercial drones and robotics.
- Notable voices: JPMorgan analysts (downgrade to Neutral, Sept 15) represent the bearish institutional view; Argus (Buy, $64, Aug 13) and Barclays (Overweight, $65, Aug 10) the more constructive camp despite trimming; CEO Kevin Clark is the most visible company voice, both promoting the robotics/drone pipeline and putting personal capital behind the stock in August.
- Sentiment shift (past 30 days): Deteriorated further — the JPMorgan downgrade (Sep 15) and FTSE All-World removal (Sep 19) both landed in September, layered on the August cut. No evidence yet of a sentiment bottom.
- Sentiment score: 2/5 (bearish-leaning; institutional downgrades and index-flow pressure dominate, partially offset by insider buying).
Pete's Read: The fundamentals are being reinforced, not contradicted, by the news flow — China auto weakness and launch delays drove a real guidance cut on Aug 4, which cascaded into sequential sell-side target trims and a technical index-removal event in September, a classic "bad news keeps finding new ways to show up" pattern. What fundamentals alone would miss is the insider-buying cluster right after the August selloff set against a market that has kept selling anyway — a genuine divergence worth tracking, not a reason to call a bottom. Retail/social attention is essentially absent, which argues for less sentiment-noise risk but also less of a catalyst for a sharp reflexive bounce.
11. Bull vs Bear Case
| Bull Case | Bear Case | |
|---|---|---|
| Valuation | 5.9x EV/EBITDA and 7.7x forward adj. EPS vs peer median 9.8x / 15.7x — a full multiple turn-plus of re-rating available | Cheap for a reason: terminal share loss justifies a structurally lower multiple, and 2026 guidance may not be the trough |
| The 40% decline | Roughly half artifact — spin-adjusted 1-yr TSR is ≈ −19.3%, 6-mo ≈ flat | The post-spin 3-month −26.74% is entirely real and entirely about deteriorating fundamentals |
| China | Cyclical destocking and launch timing; multinational OEM programs resume | Chinese domestic/NEV OEMs are permanently taking share from Aptiv's core customer base — ~$150M of the $300M cut |
| Balance sheet | D/E down to ~0.6x, $1,847M notes retired, $1.8B buyback authorization live | FCF of just $12M in Q2'26; Fitch Rating Watch Negative unresolved; less scale to absorb a downturn |
| Margins | Guided 18.4% FY26 adj. EBITDA margin on a cleaner post-spin mix; 200bps expansion targeted through 2028 | Investor Day framework (4–7% growth) was contradicted within nine months by the August cut |
| Insiders / flows | CEO and three directors bought $47–$50 with personal capital | They are already underwater; FTSE deletion adds forced passive selling with no natural buyer |
| Optionality | Robotics/drones targeted at ~$300M annual revenue; >$500M lifetime drone award | Immaterial to near-term earnings; a narrative, not a model input yet |
12. The Verdict
| Item | Call |
|---|---|
| Rating | BUY |
| Fair Value | $58 — blend of ~10x FY2026E adjusted EPS midpoint $5.70 (≈$57) and an EV/EBITDA re-rating toward the ~8x peer range off $2.34B guided EBITDA (≈$67) |
| 12-Month Price Target | $58 (+31.4% vs $44.16) |
| Entry Zone | $41.50–$43.50 — stage entries; do not chase above $46 |
| Stop Loss | $40.00 (clean break of the $41.52 five-year low) |
| Conviction | Medium |
| Position Sizing | Below full size. Valuation is compelling, momentum is not. |
| Key Risk | Structural loss of share to Chinese domestic/NEV OEMs, which already drove roughly half of the $300M FY2026 guidance cut and threatens Aptiv's core multinational-OEM customer base on a multi-year basis, not just a cyclical quarter |
| What Would Change Our Mind | Bullish: Oct 29 Q3 print holds the 18.4% EBITDA margin guide with stabilizing China volumes. Bearish: a second guidance cut on Oct 29, or a close below $40 on expanding volume. |
Reconciling the desk. Jeb (fundamentals) carries a $58 fair value at Medium conviction. Ant (technicals) says WAIT FOR PULLBACK — fresh 200-day low, death cross, thin bounce volume. Pete (sentiment) scores 2/5 with no bottom in sight. We resolve this as a BUY on a staged basis: the valuation and spin-adjustment work are strong enough to justify owning the name, but all three analysts independently flag that nothing in the price action or news flow says the selling is done. Buy the $41.50–$43.50 zone in tranches rather than the current $44.16 print, keep the stop at $40, and treat the October 29 earnings release as the thesis checkpoint.
Note on data quality: this report corrected two vendor errors (a wrong Q2'26 revenue figure of $1.220B versus the actual $3.3B, and an unadjusted price history that overstated the 1-year decline by ~21 percentage points) and flags three figures as formally unresolved (trailing EPS, trailing P/E, exact 6/30/2026 book value) because the trailing four quarters straddle the April 1, 2026 spin-off. We have not published a trailing multiple we cannot stand behind.
Disclaimer: For informational purposes only. Not investment advice.